Medical Oncology Consultant
Prof. Thistlethwaite is an Honorary Senior Lecturer at The University of Manchester. She graduated from The University of Cambridge MB PhD programme in 1999. Her PhD, under the supervision of Professor Sir Martin Evans, explored the molecular mechanisms that lead to cancer in inherited breast cancer syndromes.
Following training posts at Liverpool Royal, The Royal Marsden and The Christie, she became a consultant at The Christie in 2007. Her clinical practice is in Experimental Cancer Medicine and immune-oncology and her academic focus is clinical trial development in immunotherapy and adoptive T-cell therapy.
Prof. Thistlethwaite is a member of the ESMO Congress Scientific Committee (Immunotherapy Track) and has been an invited speaker at ESMO Congress and also hosted an immuno-oncology preceptorship meeting at The Christie School of Oncology. Fiona leads a recently formed Manchester health consortium, iMATCH, which has been awarded almost £7 million by Innovate UK to ensure that more patients benefit from a new generation of advanced cell therapies